Five Pharmaceutical Companies Charged in Ongoing Criminal Anti-Trust Investigation

With the announcement of another pharmaceutical company being charged for conspiring to fix prices for generic drugs, the Department of Justice has now charged five companies involved in this activity as the result of an ongoing antitrust investigation. Glenmark Pharmaceuticals Inc., the most recently charged company, allegedly worked with Apotex Corp. to increase and maintain prices of Pravastatin and other generic drugs.